Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Davita Healthcare Partners Inc (DVA)

Davita Healthcare Partners Inc (DVA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 11,924,600
  • Shares Outstanding, K 109,400
  • Annual Sales, $ 11,551 M
  • Annual Income, $ 773,640 K
  • 60-Month Beta 1.28
  • Price/Sales 1.01
  • Price/Cash Flow 7.69
  • Price/Book 7.46
Trade DVA with:

Options Overview

Details
  • Implied Volatility 30.28%
  • Historical Volatility 21.42%
  • IV Percentile 12%
  • IV Rank 18.92%
  • IV High 53.19% on 04/13/20
  • IV Low 24.93% on 08/21/20
  • Put/Call Vol Ratio 0.24
  • Today's Volume 333
  • Volume Avg (30-Day) 478
  • Put/Call OI Ratio 0.62
  • Today's Open Interest 4,852
  • Open Int (30-Day) 4,341

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate 1.79
  • Number of Estimates 5
  • High Estimate 1.95
  • Low Estimate 1.65
  • Prior Year 1.83
  • Growth Rate Est. (year over year) -2.19%

Price Performance

See More
Period Period Low Period High Performance
1-Month
105.08 +3.73%
on 04/01/21
111.41 -2.16%
on 03/25/21
+1.37 (+1.27%)
since 03/09/21
3-Month
98.55 +10.60%
on 02/23/21
125.28 -12.99%
on 01/12/21
-14.89 (-12.02%)
since 01/08/21
52-Week
71.70 +52.02%
on 04/24/20
125.28 -12.99%
on 01/12/21
+34.18 (+45.68%)
since 04/09/20

Most Recent Stories

More News
DaVita (DVA) Partners With Fresenius, Boost Home Dialysis Care

DaVita's (DVA) recent collaboration will help patients benefit from the portability, dependability and flexibility of NxStage home machines, designed to be easy to use.

BAX : 84.92 (+1.10%)
DVA : 109.00 (+2.00%)
FMS : 37.60 (+0.21%)
BSX : 39.32 (+1.55%)
DaVita Shares Strategy for Achieving a Diverse Community Where Everyone Belongs

, /PRNewswire/ --  today published its inaugural report, which discloses its diversity metrics and roadmap for delivering its vision of cultivating "a diverse Village where everyone belongs."

DVA : 109.00 (+2.00%)
6 Reasons Why Select Medical (SEM) Stock Looks Attractive

Select Medical's (SEM) prolific lines of business, top-line growth, proven financial performance and strong cash flow, inorganic growth profile, partnerships with healthcare system giants bode well.

DVA : 109.00 (+2.00%)
CYH : 11.92 (+2.23%)
THC : 52.19 (+2.80%)
SEM : 34.77 (+0.43%)
DaVita Statement on Government's Nationwide Program to Vaccinate Dialysis Patients

, /PRNewswire/ -- Today, the Biden administration announced a new partnership with dialysis providers to provide COVID-19 vaccinations to people receiving dialysis and health care personnel in outpatient...

DVA : 109.00 (+2.00%)
DaVita Kidney Care Expands Use of NxStage Home Hemodialysis Machines from Fresenius Medical Care

and , /PRNewswire/ -- (FMCNA) and today announced an expanded agreement to provide home dialysis technology—including NxStage home hemodialysis (HHD) machines, dialysis supplies, and a connected health...

DVA : 109.00 (+2.00%)
NephroSant Announces $16 Million Series A, Led by DaVita Venture Group

SAN FRANCISCO, CA / ACCESSWIRE / March 16, 2021 / NephroSant, a kidney health spin out of UC San Francisco, today announced it has closed its oversubscribed Series A funding round of $16 million. led...

DVA : 109.00 (+2.00%)
DaVita HealthCare (DVA) Down 4.3% Since Last Earnings Report: Can It Rebound?

DaVita HealthCare (DVA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

DVA : 109.00 (+2.00%)
DaVita Inc. to Participate in the 2021 Barclays Global Healthcare Conference

, /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced today that the company will participate in the 2021 Barclays Global Healthcare Conference.  , DaVita's Chief Financial Officer, will answer questions...

DVA : 109.00 (+2.00%)
4 Warren Buffett Stocks to Add to Your Portfolio

Warren Buffett lays special emphasis on choosing companies with strong fundamentals and holding on to them. Many investors track how Buffett optimizes his investment portfolio periodically. General Motors...

GM : 60.16 (+0.12%)
KR : 37.78 (+1.48%)
DVA : 109.00 (+2.00%)
AXTA : 29.87 (+1.05%)
DaVita Inc. Announces Upsize and Pricing of Add-On Offering of $1 Billion Senior Notes

, /PRNewswire/ -- DaVita Inc. (NYSE: DVA) ("DaVita") announced today the upsize and pricing of its previously announced private add-on offering of aggregate principal amount of its 4.625% senior notes...

DVA : 109.00 (+2.00%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Buy with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

DaVita Inc. is the parent company of DaVita Kidney Care and HealthCare Partners. DaVita Kidney Care is a provider of kidney care, delivering dialysis services for chronic kidney failure and end stage renal disease primarily in the United States. HealthCare Partners manages and operates medical groups...

See More

Key Turning Points

3rd Resistance Point 111.94
2nd Resistance Point 110.51
1st Resistance Point 109.76
Last Price 109.00
1st Support Level 107.57
2nd Support Level 106.14
3rd Support Level 105.38

See More

52-Week High 125.28
Last Price 109.00
Fibonacci 61.8% 104.81
Fibonacci 50% 98.49
Fibonacci 38.2% 92.17
52-Week Low 71.70

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar